Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Vancomycin + Tobramycin

Phase 2Small molecule

UUniversity Hospital, Linkoeping

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Arthroplasty, Replacement, HipRecruiting

Arthroplasty, Replacement, HipPhase 2

Recruiting

Timeline

Expected Milestones

Q4 2031

Phase 2Recruiting

Arthroplasty, Replacement, Hip

NCT05169229

Clinical

Trials by Indication[1]

Arthroplasty, Replacement, Hip1 trial

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. The ABOGRAFT Trial

Recruiting·UUniversity Hospital, Linkoeping·Phase 2·NCT05169229·1,100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Vancomycin + Tobramycin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Vancomycin + Tobramycin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Vancomycin + Tobramycin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Linkoeping company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity Hospital, Linkoeping

Related News